Carry-over [General Sta­tis­tics]

posted by dshah  – India, 2023-10-04 13:22 (597 d 10:53 ago) – Posting: # 23738
Views: 5,285

Hi AchievWin!

❝ <5% of Cmax rule is not applied (this is a news for me)


Any example-Pls give me? As suggested by Helmut- if you are talking about endogenous substance, then the base line correction method would play a significant role.

Honestly, I have seen some carry over- but the protocol does take care of it.
Can you share the protocol's inclusion/exclusion criteria for PK/stat part?

Regards,
Divyen

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,683 registered users;
38 visitors (0 registered, 38 guests [including 24 identified bots]).
Forum time: 00:16 CEST (Europe/Vienna)

Pharmacokinetics may be simply defined as
what the body does to the drug,
as opposed to pharmacodynamics, which may be defined as
what the drug does to the body.    Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5